CellMax Life Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$9M
Industry:Biotech
Founded:2013
Lead Investor(s):Artiman Ventures, several Taiwanese venture

Industry Ranking

Estimated Revenue & Financials

  • CellMax Life's estimated annual revenue is currently $6.5M per year.
  • CellMax Life received $9.0M in venture funding in July 2016.
  • CellMax Life's estimated revenue per employee is $155,000
  • CellMax Life's total funding is $9M.

Employee Data

  • CellMax Life has 42 Employees.
  • CellMax Life grew their employee count by 14% last year.
  • CellMax Life currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$18.6M120N/AN/A-N/A
#8
$23.3M150N/AN/A-N/A
#9
$33.3M2153%N/A-N/A
#10
$28.7M1858%N/A-N/A
Missing a competitor? Contribute!?
Submit

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax's unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

42

Number of Employees

$6.5M

Revenue (est)

1

Current Jobs

14%

Employee Growth %

$9M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

CellMax Life News

09/03/2019 - CellMax Life blood test study detects precancer colorectal ...

A study by CellMax Life found that the company's blood-based test was able to detect the small, precancerous colon polyps known as ...

09/08/2019 - Anatomic Pathology Market Value Trend 2019 Estimated Size ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

09/03/2019 - Anatomic Pathology Market 2019 Size, Share, Future ...

... CellMax Life, Digipath, Biocare Medical, AdnaGen, Angsana Molecular & Diagnostics Laboratory, Enzo Biochem, Cancer Genetics, Biocartis, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$6.1M4240%N/A-N/A
#2
$10.5M43-27%N/A-N/A
#3
$14.1M4330%N/A-N/A
#4
$6.2M43N/AN/A-N/A
#5
$8.8M43N/AN/A-N/A

CellMax Life Funding

DateAmountRoundLead InvestorsReference
2016-07-27$9.0MA-1Artiman VenturesArticle